ENLV   $1.54  -5.52% Market Closed After Close 1.56 1.30%

Enlivex Therapeutics Ltd
Total Cash 25.94M
totalCashPerShare 1.242
EBITDA -17.89M
Total Debt 835.00K
quickRatio 9.574
currentRatio 10.056
Total Revenue
debtToEquity 2.923
Revenue/Share
ROA -0.27456
ROE -0.61166
grossProfits
freeCashflow -11.98M
operatingCashflow -17.02M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 7.26M
forwardPE -2.6724138
floatShares 15.60M
sharesOutstanding 21.41M
sharesShort 104.62K
sharesShortPriorMonth 94.56K
dateShortInterest
sharesPercentSharesOut 0.00%
heldPercentInsiders 0.06%
heldPercentInstitutions 0.17%
Short Ratio help_outline 0.70%
shortPercentOfFloat 0.01%
impliedSharesOutstanding
bookValue 1.368
Price To Book help_outline 1.13
earningsQuarterlyGrowth
netIncomeToCommon -22.29M
trailingEps -1.18%
forwardEps -0.58%
enterpriseToEbitda -0.41
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.18 3Q 2024
institutionsCount 20
lastUpdated Oct. 16, 2024, 12:28 p.m.